The Director of Bioanalysis for B Cell Therapy is responsible for building and leading a team of scientists to develop bioanalytical plans and be involved in the design, development, qualification, and validation of quantitative assays supporting B cell therapy research and development. This is an exciting opportunity at Be Bio, which is creating a bold new class of cell therapies and is advancing B cell therapy to clinic.

Role & Responsibilities:

  • Build up our bioanalytical capability to support B cell therapy programs at both research and development stages
  • Builds and retains a team of high-performing scientists & RAs that can realize the company’s goals
  • Act as the subject matter expert (SME) in protein assays (e.g., LC-MS, ELISA), molecular assays (e.g., qPCR, ddPCR etc.), and cellular assays (e.g., flow cytometry, ELISpot etc.) development, qualification, and validation
  • Be involved in the design, development, qualification, and validation of quantitative assays supporting B cell therapy programs from research to clinic.
  • Develop internal guidelines for bioanalytical method development and ruggedness evaluation of assay in support of in vivo studies
  • Identify CROs, oversee method development in house or at identified CROs, method transfer and method validation at CROs. Ensures bioanalytical method development is performed with a level of rigor and validation appropriate for stage of research and development ensuring compliance with internal guidelines, SOPs and regulatory guidelines.
  • Review data for scientific rigor and ensure project compliance with external regulatory requirements and internal guidelines
  • Review and approve method qualification/validation reports and sample analysis reports.
  • Drive innovation within Bioanalysis and keep up to date of new technologies and instrumentation for implementation of new experimental strategies.
  • The ability to deliver clear, concise, and persuasive oral, and written communications is required.
  • Key interdepartmental collaborations will include Research, Technical Operation, and Clinical group to ensure adequate and timely bioanalytical support of non-GLP and GLP preclinical and clinical studies.
  • Maintain and support safe lab practices and environment.

Experience, Education, Specialized Knowledge, and Skills:

Must thrive in a fast-paced, growing, and innovative environment where flexibility, resourcefulness, resiliency, and communication skills are key. Excellent interpersonal skills, ability to develop important relationships with your stakeholders, and being an all-around good company citizen are essential. Demonstrated ability to manage a high-performing team where collaboration and innovation are essential. 

  • Ph.D. or Master’s degree in biology, immunology, chemistry, pharmacology, or related scientific fields required with 10+ years' relevant experience.
  • Demonstrated experience and expertise in developing and establishing bioanalytical methods to support cell and gene therapy programs
  • Strong background in protein assays (e.g., LC-MS, ELISA), molecular techniques (qPCR, ddPCR etc.) and cellular assays such as flow cytometry, ELISpot etc.
  • Knowledge of current regulatory guidance and industry best practices in cell and gene therapy bioanalysis
  • Familiar with requirements of FDA/EMA, GLP/GCLP regulations, and ICH guidelines.
  • Great leadership experience in both project and people management is required.
  • Ability to achieve objectives/timelines through collaborative efforts with coworkers, managers, and CROs.
  • Ability to work independently and have good attention to the details.
  • Background in B cell biology/immunology highly desirable

About Be Biopharma

Be Biopharma (“Be Bio”) is pioneering Engineered B Cell Medicines (BeCM) to dramatically improve patients’ lives who are living with cancer, rare diseases and other serious conditions. With eyes locked on the patient, our team of purpose-driven scientists, technologists, manufacturing experts and business builders collaborate to create a bold new class of cell therapies. Be Bio was founded in October 2020 by Longwood Fund and B cell engineering pioneers David Rawlings, M.D., and Richard James, Ph.D. from Seattle Children’s Research Institute. Be Bio is backed by ARCH Venture Partners, Atlas Venture, RA Capital Management, Alta Partners, Longwood Fund, Bristol Myers Squibb and Takeda Ventures. Since our founding, Be Bio’s investors have committed over $180 million to enable the Company to re-imagine medicine based on the power of B cell therapy. For more information, please visit us at Be.Bio and our LinkedIn page.

Culture

The beating heart of Be Bio is our People and together we are building a culture driven by purpose, passion, and that’s full of character.  We are “all-in” as we align ourselves with patients who need our medicines, and we embrace the highest standards of transparency, excellence, candor, collaboration, and team-based science with a shared ownership of company milestones and successes. 

Our commitment to our team members is to deliver a compelling, dynamic work experience that enables them to continually stretch, grow, and learn, that enriches their lives, that fosters a sense of belonging and community, and that goes above and beyond to support them in big, meaningful ways in both their personal and professional lives.  Be Bio is a team that works hard, plays hard, and supports each other on our shared journey to get transformative medicines to patients who need them. 

 

 

 

 

Apply for this Job

* Required
resume chosen  
(File types: pdf, doc, docx, txt, rtf)
cover_letter chosen  
(File types: pdf, doc, docx, txt, rtf)
When autocomplete results are available use up and down arrows to review
+ Add Another Education


Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in Be Biopharma, Inc.’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.


Form CC-305

OMB Control Number 1250-0005

Expires 05/31/2023

Voluntary Self-Identification of Disability

Why are you being asked to complete this form?

We are a federal contractor or subcontractor required by law to provide equal employment opportunity to qualified people with disabilities. We are also required to measure our progress toward having at least 7% of our workforce be individuals with disabilities. To do this, we must ask applicants and employees if they have a disability or have ever had a disability. Because a person may become disabled at any time, we ask all of our employees to update their information at least every five years.

Identifying yourself as an individual with a disability is voluntary, and we hope that you will choose to do so. Your answer will be maintained confidentially and not be seen by selecting officials or anyone else involved in making personnel decisions. Completing the form will not negatively impact you in any way, regardless of whether you have self-identified in the past. For more information about this form or the equal employment obligations of federal contractors under Section 503 of the Rehabilitation Act, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp.

How do you know if you have a disability?

You are considered to have a disability if you have a physical or mental impairment or medical condition that substantially limits a major life activity, or if you have a history or record of such an impairment or medical condition.

Disabilities include, but are not limited to:

  • Autism
  • Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, or HIV/AIDS
  • Blind or low vision
  • Cancer
  • Cardiovascular or heart disease
  • Celiac disease
  • Cerebral palsy
  • Deaf or hard of hearing
  • Depression or anxiety
  • Diabetes
  • Epilepsy
  • Gastrointestinal disorders, for example, Crohn's Disease, or irritable bowel syndrome
  • Intellectual disability
  • Missing limbs or partially missing limbs
  • Nervous system condition for example, migraine headaches, Parkinson’s disease, or Multiple sclerosis (MS)
  • Psychiatric condition, for example, bipolar disorder, schizophrenia, PTSD, or major depression

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.